02/14/2024 2:18 PM | ARCH Venture Fund IX, L.P. (Filed by) Lyell Immunopharma (Subject)
| Form SC 13G/A | |
02/13/2024 7:22 PM | Lee Gary K. (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 7:24 PM | Hill Stephen J. (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 7:25 PM | Lang Matthew (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 7:17 PM | Lyell Immunopharma (Issuer) Seely Lynn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 7:19 PM | Lyell Immunopharma (Issuer) Newton Charles W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Lyell Immunopharma (Subject)
| Form SC 13G | |
|
11/20/2023 7:53 PM | Lyell Immunopharma (Issuer) Seely Lynn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 7:54 PM | Lee Gary K. (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 7:55 PM | Lyell Immunopharma (Issuer) Newton Charles W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 7:52 PM | Hill Stephen J. (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 3:26 PM | Lyell Immunopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 3:14 PM | Lyell Immunopharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/11/2023 8:16 AM | Lyell Immunopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/08/2023 3:20 PM | Bishop Hans Edgar (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 3:22 PM | BRAWLEY OTIS W (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 3:23 PM | Lyell Immunopharma (Issuer) NABEL ELIZABETH G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 3:24 PM | Lyell Immunopharma (Issuer) NELSEN ROBERT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 3:26 PM | FRIEDMAN CATHY (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 3:27 PM | Lyell Immunopharma (Issuer) RIEFLIN WILLIAM JL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/17/2023 3:23 PM | Klausner Richard (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 2:04 PM | Klausner Richard (Reporting) Lyell Immunopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 2:08 PM | Klausner Richard (Reporting) Lyell Immunopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 2:16 PM | Klausner Richard (Reporting) Lyell Immunopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 2:19 PM | Klausner Richard (Reporting) Lyell Immunopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/20/2023 12:07 PM | Lang Matthew (Reporting) Lyell Immunopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/17/2023 4:42 PM | Klausner Richard (Reporting) Lyell Immunopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023 4:47 PM | Klausner Richard (Reporting) Lyell Immunopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023 4:32 PM | Klausner Richard (Reporting) Lyell Immunopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023 4:36 PM | Klausner Richard (Reporting) Lyell Immunopharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023 3:47 PM | Lyell Immunopharma (Issuer) NABEL ELIZABETH G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 3:49 PM | Lyell Immunopharma (Issuer) NELSEN ROBERT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 3:51 PM | Lyell Immunopharma (Issuer) RIEFLIN WILLIAM JL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 3:40 PM | Bishop Hans Edgar (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 3:41 PM | BRAWLEY OTIS W (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 3:43 PM | FRIEDMAN CATHY (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 3:45 PM | Klausner Richard (Reporting) Lyell Immunopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |